PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit”) on behalf of the Company’s investors.
The investigation seeks to determine whether Summit issued false and misleading statements and/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company’s shareholders.
Summit shareholders
are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (
[email protected]
) or online at
https://kaskelalaw.com/cases/summit-therapeutics/
, for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.
CONTACT:
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
www.kaskelalaw.com
